Zvonko Kusić

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Alexander M.M. Eggermont, Stefan Suciu, Mario Santinami et al. · The Lancet · 2008 · 638 citations

Surgical Oncology, Medicine, Eortc 18991 +7

Thyroglobulin Is a Sensitive Measure of Both Deficient and Excess Iodine Intakes in Children and Indicates No Adverse Effects on Thyroid Function in the UIC Range of 100–299 μg/L: A UNICEF/ICCIDD Study Group Report

Michael Zimmermann, Isabelle Herter‐Aeberli, Maria Andersson et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 206 citations · Full text

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group

Andrew Bottomley, Corneel Coens, Stefan Suciu et al. · Journal of Clinical Oncology · 2009 · 116 citations · Full text

EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

Eggermont Am, Stefan Suciu, Mario Santinami et al. · Research Explorer (The University of Manchester) · 2008 · 111 citations

Surgical Oncology, Eortc Melanoma Group, Medicine +9

Standardized Map of Iodine Status in Europe

Till Ittermann, Diana Albrecht, Petra Arohonka et al. · Thyroid · 2020 · 90 citations · Full text